Rockefeller Capital Management L.P. Nektar Therapeutics Transaction History

Rockefeller Capital Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$3.04 - $5.14 $474 - $801	156 New	156 $0
Q3 2021 Nov 12, 2021	SELL	$13.07 - $18.84 $5,228 - $7,536	-400 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $3,705 - $4,472	-235 Reduced 37.01%	400 $6,000
Q3 2020 Nov 13, 2020	BUY	$16.59 - $24.79 $1,459 - $2,181	88 Added 16.09%	635 $10,000
Q2 2020 Aug 12, 2020	SELL	$16.86 - $23.44 $1,888 - $2,625	-112 Reduced 17.0%	547 $13,000
Q1 2020 May 12, 2020	BUY	$14.47 - $27.96 $3,385 - $6,542	234 Added 55.06%	659 $12,000
Q4 2019 Feb 07, 2020	BUY	$15.87 - $23.12 $396 - $578	25 Added 6.25%	425 $9,000
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $6,764 - $14,508	400 New	400 $7,000
Q2 2019 Aug 09, 2019	SELL	$31.0 - $36.3 $6,944 - $8,131	-224 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$31.58 - $46.35 $7,073 - $10,382	224 New	224 $8,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.